Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Secukinumab and covid vaccines?What type of protein does lipitor mainly interact with?Can lipitor cause significant flexibility loss over time?How do lipitor's side effects compare to other statins?Are prolia's biosimilars as safe as the original drug?
See the DrugPatentWatch profile for tremfya
How does Tremfya bind to the p19 subunit of IL-23? Tremfya is a monoclonal antibody that binds the p19 subunit of IL-23, preventing the cytokine from interacting with its receptor. The antibody does not bind to the p40 subunit that IL-23 shares with IL-12, giving it selectivity for the IL-23 pathway. Why do companies target the p19 subunit specifically? Targeting the p19 subunit keeps the antibody from interfering with IL-12-mediated responses. Researchers developed selective p19 inhibitors after observing that broad inhibition of both IL-12 and IL-23 might affect host defense against intracellular pathogens. Selective p19 targeting reduces those theoret
Other Questions About Tremfya :